Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01068639
NCT01068639
Withdrawn
Not Applicable

IMprove PAtient Compliance sTudy: An Observational, Cross-sectional Study on Children Treated With Growth Hormone in France

Novo Nordisk A/S0 sitesFebruary 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGrowth Hormone DisorderGrowth Hormone Deficiency in Children

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Growth Hormone Disorder
Sponsor
Novo Nordisk A/S
Primary Endpoint
Average number of injections omitted during the previous month
Status
Withdrawn
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
April 2010
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Child treated for at least one year with growth hormone any growth hormone product
  • •Followed by the participating paediatrician for at least 1 year.

Exclusion Criteria

  • •Refusal to participate
  • •Child and/or parent unable to give consent or fill out the questionnaires
  • •Child participating in a therapeutic trial

Outcomes

Primary Outcomes

Average number of injections omitted during the previous month

Time Frame: measured over the past 2 months (retrospective data collection)

Similar Trials

Terminated
Not Applicable
Lexington Observational Study of Treatment With Compounded Pain CreamsChronic PainAcute Pain
NCT02195752Lexington Independent Studies, LLC26
Completed
Not Applicable
A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected MelanomaMelanoma
NCT01986712St. Luke's Hospital and Health Network, Pennsylvania50
Completed
Not Applicable
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for InhalationPulmonary Hypertension
NCT01894035Bayer13
Completed
Not Applicable
AdHerencE to Treatment and quAlity of Life in COPDChronic Obstructive Pulmonary DiseaseCompliance, PatientQuality of Life
NCT03299673Elpen Pharmaceutical Co. Inc.600
Completed
Phase 4
Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND OptimisationChronic Myelogenous Leukemia (CML)
NCT01243489Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH104